智醫科學

AI醫療技術、應用與市場動態

【醫材】《Imvaria》特發性肺纖維化(IPF)與《Darmiyan》失智症AI工具獲FDA授權

 【醫材】《Imvaria》特發性肺纖維化(IPF)與《Darmiyan》失智症AI工具獲FDA授權


 文章出處  

Medtechdive 

 

 原文標題  

Imvaria and Darmiyan receive FDA authorizations for AI-enabled diagnostic tools 

 

 Twitter  

https://twitter.com/aimedadviser/status/1748972278715646073 

 

 文章序號  

5002 

 

智醫科學-AI醫療技術、應用與市場動

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.